United Therapeutics Corp
UTH
Company Profile
Business description
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
Contact
1000 Spring Street
Silver Spring MD 20910
USAT: +1 301 608-9292
E: ir@unither.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
1,168
Stocks News & Analysis
stocks
An undervalued wide moat US share with momentum
Shares of this high-quality company have rallied recently but still look attractive.
stocks
3 shares with high dividend yields from our Global Best Ideas list
These three picks trade at a significant discount to our fair value and all offer dividend yields above 4.5%.
video
Our view of mining shares
Morningstar Equity Analyst Jon Mills walks through our view of the sector and opportunities for investors.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,208.60 | 42.20 | 0.52% |
| CAC 40 | 7,598.63 | 23.39 | -0.31% |
| DAX 40 | 18,557.70 | 150.63 | 0.82% |
| Dow JONES (US) | 40,358.09 | 57.35 | -0.14% |
| FTSE 100 | 8,167.37 | 31.41 | -0.38% |
| HKSE | 17,469.36 | 166.52 | -0.94% |
| NASDAQ | 17,997.35 | 10.22 | -0.06% |
| Nikkei 225 | 39,594.39 | 4.61 | -0.01% |
| NZX 50 Index | 12,411.19 | 14.39 | -0.12% |
| S&P 500 | 5,555.74 | 8.67 | -0.16% |
| S&P/ASX 200 | 7,971.10 | 39.40 | 0.50% |
| SSE Composite Index | 2,915.37 | 48.85 | -1.65% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Argosy Minerals Ltd AGY | 0.06 | 0.03 | -30.86% |
| Worley Ltd WOR | 15.10 | 0.09 | -0.59% |
| Pilbara Minerals Ltd PLS | 2.87 | 0.03 | -0.87% |
| Imugene Ltd IMU | 0.06 | 0.00 | -5.00% |
| Droneshield Ltd DRO | 1.34 | 0.08 | -5.63% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.03% |
| 4DS Memory Ltd 4DS | 0.09 | 0.01 | -7.61% |
| Mesoblast Ltd MSB | 1.23 | 0.07 | -5.56% |
| Core Lithium Ltd CXO | 0.10 | 0.00 | -2.04% |
| South32 Ltd S32 | 2.93 | 0.05 | -1.68% |